🔎 Trials Near Me

Pradžia › Limfoma › Ilinoisas › Chicago

Limfoma klinikiniai tyrimai Chicago, IL

20 tyrimai dėl Limfoma ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Renkami dalyviai2 fazė
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07015242

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Renkami dalyviai1/2 fazė
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-09-11 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Renkami dalyviai3 fazė
  • Research Site, Chicago
Amžius nuo 18 iki 18 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07509151

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Renkami dalyviai1 fazė
  • University of Illinois Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT06624085

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Renkami dalyviai1/2 fazė
  • University of Chicago, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07284433

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Renkami dalyviai1/2 fazė
  • University of Chicago Medical Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Renkami dalyviai1 fazė
  • The David and Etta Jonas Center for Cellular Therapy, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Renkami dalyviai3 fazė
  • Northwestern, Chicago
  • University of Chicago, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-04 · NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

Renkami dalyviai
  • Northwestern University Feinberg School of Medicine, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-03 · NCT06960993

DALY II USA/ MB-CART2019.1 for DLBCL

Renkami dalyviai2 fazė
  • Robert H Lurie Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT04792489

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Renkami dalyviai1/2 fazė
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · Visoms lytims · Atnaujinta 2026-07-06 · NCT02332668

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Renkami dalyviai1 fazė
  • Northwestern University, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT05131022

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Renkami dalyviaiStebimasis tyrimas
  • Lurie Children's Hospital-Chicago, Chicago
Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Renkami dalyviai1/2 fazė
  • Northwestern Memorial Hospital, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Renkami dalyviai1/2 fazė
  • University of Illinois at Chicago Cancer Center, Chicago
Amžius nuo 12 iki 95 · Visoms lytims · Atnaujinta 2026-04-15 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Renkami dalyviai1 fazė
  • The University of Chicago Medical Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-20 · NCT04830137

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

Renkami dalyviai1/2 fazė
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-04 · NCT07294677

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Renkami dalyviai
  • University of Chicago Comprehensive Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-20 · NCT05745285

Avo In R/R And Previously Untreated MCL

Renkami dalyviai1/2 fazė
  • University of Chicago Medical Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-21 · NCT04855695

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Renkami dalyviai1 fazė
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-22 · NCT04234048

Limfoma tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.